Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Covington
Cerilliant
Farmers Insurance
McKinsey
Colorcon
QuintilesIMS
Argus Health
Harvard Business School

Generated: December 14, 2018

DrugPatentWatch Database Preview

FOSINOPRIL SODIUM Drug Profile

« Back to Dashboard

Which patents cover Fosinopril Sodium, and what generic alternatives are available?

Fosinopril Sodium is a drug marketed by Actavis Labs Fl Inc, Apotex Inc, Aurobindo Pharma Ltd, Invagen Pharms, Prinston Inc, Ranbaxy Labs Ltd, Teva, Upsher Smith Labs, Watson Labs, Aurobindo Pharma, Emcure Pharms Ltd, Mylan, Sandoz, and Sun Pharm Inds Ltd. and is included in twenty NDAs.

The generic ingredient in FOSINOPRIL SODIUM is fosinopril sodium; hydrochlorothiazide. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the fosinopril sodium; hydrochlorothiazide profile page.

Drug patent expirations by year for FOSINOPRIL SODIUM
Pharmacology for FOSINOPRIL SODIUM
Synonyms for FOSINOPRIL SODIUM
(4S)-4-Cyclohexyl-1-(((R)-((S)-1-hydroxy-2-methylpropoxy)(4-phenylbutyl)phosphinyl)acetyl-L-proline propionate (ester), sodium salt
(4S)-4-Cyclohexyl-1-[[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetyl]-L-proline Sodium Salt
01503944_FOSINOPRIL
1217528-56-7
88889-14-9
A842989
AB2000499
AC-6227
Acecor
Acenor-M
AK-73086
AKOS015888700
AKOS025117347
AKOS026750121
AN-10220
API0002766
AS-13178
AX8046004
BCP9000703
BR-73086
BS-1003
C30H45NNaO7P
CAS-88889-14-9
CHEBI:5164
CHEMBL3039596
CHEMBL3188382
CS-2454
D00622
DR003327
DSSTox_CID_26621
DSSTox_GSID_46621
DSSTox_RID_81772
DTXSID7046621
Dynacil
Eliten
Eosinopril
FOSENOPRIL SODIUM
Fosinil
Fosinopril (sodium)
Fosinopril sodium (Monopril)
Fosinopril sodium (USAN)
Fosinopril sodium [USAN:USP]
Fosinopril sodium [USAN]
Fosinopril sodium salt
Fosinopril sodium, >=98% (HPLC), powder
Fosinopril sodium, European Pharmacopoeia (EP) Reference Standard
Fosinopril sodium, United States Pharmacopeia (USP) Reference Standard
FOSINOPRIL?SODIUM
fosinoprilsodium
Fosinorm
Fosipres
Fositen
Fositens
Foziretic
H524
Hiperlex
HMS502N10
HY-B0382
I01-1155
J90058
KB-303018
KS-00000LIV
L-Proline, 4-cyclohexyl-1-(((2-methyl-1-(1-oxopropoxy)propoxy)(4-phenylbutyl)phosphinyl)acetyl)-, sodium salt, (1(S*(R*)),2alpha,4beta)-
L-proline, 4-cyclohexyl-1-[[[2-methyl-1-(1-oxopropoxy) propoxyl] (4-phenylbutyl) phosphinyl] acetyl]-, sodium salt, trans-
LS-118920
MFCD00865785
Monopril
NCGC00167432-01
Newace
NW2RTH6T2N
Q-201135
S-5701
s2095
Sapril
SC-17358
SCHEMBL40690
Secorvas
sodium (2S,4S)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylate
Sodium (2S,4S)-4-cyclohexyl-1-(2-((2-methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetyl
Sodium (2S,4S)-4-cyclohexyl-1-(2-((2-methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetyl)pyrrolidine-2-
Sodium (2S,4S)-4-cyclohexyl-1-(2-((2-methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetyl)pyrrolidine-2-carboxylate
sodium (2S,4S)-4-cyclohexyl-1-(2-{[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylate
sodium (2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxy-propoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate
sodium 4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxy-propoxy)-(4-phenylbutyl)phosphoryl]ethanoyl]pyrrolidine-2-carboxylate
sodium 4-cyclohexyl-1-[2-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphoryl]-1-oxoethyl]-2-pyrrolidinecarboxylate
sodium fosinopril(1-)
SQ 28555
ST2419394
ST51051568
Staril
Tenso Stop
Tensogard
Tox21_112436
TVTJZMHAIQQZTL-WATAJHSMSA-M
UNII-NW2RTH6T2N

US Patents and Regulatory Information for FOSINOPRIL SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Invagen Pharms FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 090228-002 Jul 9, 2009 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs FOSINOPRIL SODIUM fosinopril sodium TABLET;ORAL 076987-003 Dec 23, 2004 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 076945-002 Jul 5, 2006 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 076961-002 Sep 28, 2005 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 077144-001 Aug 16, 2005 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs FOSINOPRIL SODIUM fosinopril sodium TABLET;ORAL 076987-001 Dec 23, 2004 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Covington
Cerilliant
Farmers Insurance
McKinsey
Colorcon
QuintilesIMS
Argus Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.